These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Patients' concern about their medicine after a generic switch: a combined cross-sectional questionnaire and register study. Rathe J, Søndergaard J, Jarbøl DE, Hallas J, Andersen M. Pharmacoepidemiol Drug Saf; 2014 Sep; 23(9):965-73. PubMed ID: 24946275 [Abstract] [Full Text] [Related]
3. Generic switching and non-persistence among medicine users: a combined population-based questionnaire and register study. Rathe J, Andersen M, Jarbøl DE, dePont Christensen R, Hallas J, Søndergaard J. PLoS One; 2015 Sep; 10(3):e0119688. PubMed ID: 25775472 [Abstract] [Full Text] [Related]
4. Associations between generic substitution and patients' attitudes, beliefs and experiences. Rathe J, Larsen P, Andersen M, Paulsen M, Jarbøl D, Thomsen J, Soendergaard J. Eur J Clin Pharmacol; 2013 Oct; 69(10):1827-36. PubMed ID: 23765409 [Abstract] [Full Text] [Related]
7. Exploring the opinions and experiences of patients with generic substitution: a representative study of Polish society. Drozdowska A, Hermanowski T. Int J Clin Pharm; 2015 Feb; 37(1):68-75. PubMed ID: 25428446 [Abstract] [Full Text] [Related]
8. Generic substitution of antihypertensive drugs: does it affect adherence? Van Wijk BL, Klungel OH, Heerdink ER, de Boer A. Ann Pharmacother; 2006 Jan; 40(1):15-20. PubMed ID: 16303985 [Abstract] [Full Text] [Related]
11. Evaluation of Switch-to-Brand Rates as a Potential Signal for Therapeutic Equivalency of Generic Antidepressants: A Real-World Retrospective Cohort Study. Kalaria S, Spence O, Hong K, dosReis S, Gopalakrishnan M. Clin Pharmacol Ther; 2021 Aug; 110(2):443-451. PubMed ID: 33811324 [Abstract] [Full Text] [Related]
12. Impact of substitution among generic drugs on persistence and adherence: A retrospective claims data study from 2 Local Healthcare Units in the Lombardy Region of Italy. Colombo GL, Agabiti-Rosei E, Margonato A, Mencacci C, Montecucco CM, Trevisan R, Catapano AL. Atheroscler Suppl; 2016 Jun; 21():1-8. PubMed ID: 26948872 [Abstract] [Full Text] [Related]
16. [Fifty years old and more patients' attitudes towards and experiences of generic substitution of prescription medicines]. Ringuier R, Rouquette A, Dagorne C, Garnier F, Fanello S. Therapie; 2008 Oct; 63(1):11-7. PubMed ID: 18387271 [Abstract] [Full Text] [Related]
17. Clinical and pharmacy utilization outcomes with brand to generic antiepileptic switches in patients with epilepsy. Erickson SC, Le L, Ramsey SD, Solow BK, Zakharyan A, Stockl KM, Harada AS, Curtis B. Epilepsia; 2011 Jul; 52(7):1365-71. PubMed ID: 21692778 [Abstract] [Full Text] [Related]
18. Similarity between generic and brand-name antihypertensive drugs for primary prevention of cardiovascular disease: evidence from a large population-based study. Corrao G, Soranna D, Merlino L, Mancia G. Eur J Clin Invest; 2014 Oct; 44(10):933-9. PubMed ID: 25132063 [Abstract] [Full Text] [Related]
19. Do users of risperidone who switch brands because of generic reference pricing fare better or worse than non-switchers? A New Zealand natural experiment. Lessing C, Ashton T, Davis P. Adm Policy Ment Health; 2015 Nov; 42(6):695-703. PubMed ID: 25331449 [Abstract] [Full Text] [Related]